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HypF-NSeveral human diseases are associated with the deposition of stable ordered protein aggregates known as
amyloid fibrils. In addition, a large wealth of data shows that proteins not involved in amyloidoses, are able to
form, in vitro, amyloid-like prefibrillar and fibrillar assemblies indistinguishable from those grown from
proteins associated with disease. Previous studies showed that early prefibrillar aggregates of the N-terminal
domain of the prokaryotic hydrogenase maturation factor HypF (HypF-N) are cytotoxic, inducing early
mitochondria membrane depolarization, activation of caspase 9 and eventually cell death. To gain knowledge
on the molecular basis of HypF-N aggregate cytotoxicity, we performed a differential proteomic analysis of
NIH-3T3 cells exposed to HypF-N prefibrillar aggregates in comparison with control cells. Two-dimensional
gel electrophoresis followed by protein identification by MALDI-TOF MS, allowed us to identify 21 proteins
differentially expressed. The changes of the expression level of proteins involved in stress response (Hsp60
and 78 kDa glucose-regulated protein) and in signal transduction (Focal adhesion kinase1) appear
particularly interesting as possible determinants of the cell fate. The levels of some of the differently
expressed proteins were modified also in similar studies carried out on cells exposed to Aβ or α-synuclein
aggregates, supporting the existence of shared features of amyloid cytotoxicity.© 2009 Elsevier B.V. All rights reserved.1. IntroductionAmyloid diseases are a group of protein misfolding pathologies
including either systemic forms (i.e. type II diabetes mellitus,) and
neurodegenerative diseases (Alzheimer's, Parkinson's, Huntington
and prion diseases) (reviewed in [1,2]). The molecular basis of these
clinically different pathologies can be traced back to the presence, in
the affected tissues and organs, of proteinaceous deposits of fibrillar
aggregates of one out of a number of peptides or proteins, each found
aggregated specifically in each disease (reviewed in [1,3]). In the last
ten years it has became increasingly clear that the ability to
oligomerize into amyloid assemblies is not a specific feature of the
proteins and peptides found aggregated in tissues affected by amyloid
diseases; in fact, since 1998, an increasing number of reports support
the idea that protein misfolding following mutations, chemical
modifications, presence of destabilizing surfaces or any other altera-
tion of the chemical environment, can result a structural reorganiza-oresis; IEF, isoelectrofocusing;
er desorption/ionization time-
ass spectrometry; CHAPS, 3-
nic acid; ECL, Enhanced Che-
r; HypF-N, N-terminal domain
herini).
ll rights reserved.tion, favouring oligomerization/polymerization of peptides and
proteins into amyloids [4,5].
In addition to amyloid aggregation, aggregate toxicity has also
recently resulted as a generic property of proteins and peptides. In
particular, it is increasingly recognized that amyloid oligomers,
preceding the appearance of mature fibrils, known as prefibrillar
aggregates, are the most toxic species, among amyloid assemblies
associated or not associated with disease [6,7]. This view supports the
idea that any protein can potentially become the source of toxic
species impairing cell viability and that the cytotoxicity of prefibrillar
aggregates results, at least in part, from shared basic structural
features of the latter [8]. Moreover, a growing number of studies
suggest that, in most cases, the cell membrane, can also favour
protein/peptide misfolding favouring the appearance of aggregating
nuclei [9]. Conversely, toxic prefibrillar aggregates from disease-
associated or disease-unrelated proteins can interact with the cell
membranes modifying their structural order resulting in the early
impairment of ion and redox homeostasis [10,11]. Intense efforts are
presently dedicated at unravelling the molecular basis of the
appearance in tissue of protein aggregates and their cytotoxicity.
However, muchmust still be learnt to gain enough knowledge to allow
designing therapeutic strategies aimed at counteracting the clinical
symptoms of amyloid diseases. On this respect, it can be important to
investigate the cytotoxic effects on cells exposed to amyloid
aggregates of proteins/peptides not associated with any amyloid
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shared structural features in amyloids excluding those associated with
the specific features of any aggregated peptide/protein.
The advent of proteomics has allowed the simultaneous analysis of
changes in the expression pattern of multiple proteins in complex
biological systems. This appears particularly important in the case of
cell dysfunctions resulting from protein aggregation. The effects
protein aggregates have on cells appear highly complex and hetero-
geneous. Such a complex pattern of cell impairment makes proteo-
mics one of the most useful tools to integrate these modifications into
a whole systematic picture. The reports that recently appeared on the
proteomic analysis of amyloid diseases such as Alzheimer's disease,
Parkinson's disease and others have provided valuable data on some
cell modifications allowing to explain, at least in part, cell impairment
in these diseases [12–16]. Proteomic studies provided useful informa-
tion on the changes in pattern of protein expression in cells exposed to
toxic aggregates of specific peptides/proteins found aggregated in the
corresponding diseases.
In the present study we performed a proteomic analysis of NIH-
3T3 cells exposed to toxic aggregates of a protein domain not involved
in any amyloid disease, the N-terminal domain of the prokaryotic
HypF hydrogenase maturation factor (HypF-N) whose aggregation
properties and aggregate cytotoxicity were previously characterized
[8,10,17]. To our knowledge, this is the first proteomic study on the
alterations of the protein expression profiles in cells exposed to toxic
amyloid aggregates of a disease-unrelated protein.
Our results highlight some generic changes in protein expression
pattern elicited by the shared features of amyloids such as the basic
cross-beta structure and the exposure of hydrophobic patches. We
found significant differences in the protein expression patterns in
the exposed cells, with a number of up- or down-regulated proteins.
Some of these proteins were also found in similar studies carried
out on cells exposed to Aβ or α-synuclein aggregates in agreement
with the generic nature of the cellular changes underlying amyloid
cytotoxicity. Among the differentially expressed proteins, the
reduced expression of Fak1 observed in the exposed cells can be
related to the apoptotic process, whereas the increased expression
of Hsp60 can provide protection against cell stress induced by HypF-
N prefibrillar aggregates. Furthermore the treated cells showed a
marked increase of the expression of both glyceraldehyde 3-
phosphate dehydrogenase (Gapdh) and enolase. These two proteins
are involved in energy metabolism and Gapdh has also been shown
to bind the β-amyloid precursor protein [18] and to be involved in
transcriptional regulation of cell-cycle [19]. Finally, we observed an
increase in the expression level of actin as previously shown in cell
exposed to the intracellular domain of the β-amyloid precursor
protein [20].
2. Materials and Methods
2.1. HypF-N expression and purification
HypF-N was expressed and purified as previously described [17].
HypF-N prefibrillar aggregates were obtained by incubating the
protein for 48 h at room temperature at a concentration of 0.3 mg/
ml in 30% (v/v) trifluoroethanol, 50 mM sodium acetate, 2 mM
dithiotreitol (DTT), pH 5.5, as previously reported [17]. At the end of
the incubation the solution was centrifuged, and the resulting pellet
was dried under N2 to remove the residual solvent, dissolved in DMEM
at 200 μM (monomeric protein concentration) and immediately
added to the cell culture medium at 2 μM final concentration.
2.2. Cell culture and treatment
Cell culture media and other reagents, unless otherwise stated,
were from Sigma-Aldrich Fine Chemicals Co. NIH-3T3 murinefibroblasts (ATCC,Manassas, VA)were routinely cultured inDulbecco's
modified Eagle's medium (DMEM) with 4.5 g/l glucose, containing
10% bovine calf serum (HyClone Lab, Perbio Company, Celbio), 3 mM
glutamine, 100 U/ml penicillin and 100 μg/ml streptomycin, in a 5%
CO2 humidified environment at 37 °C. Cells were used for a maximum
of 10 passages. Sub-confluent NIH-3T3 cells were treated for differing
lengths of time with 2 μM toxic HypF-N prefibrillar aggregates. Under
these conditions itwas previously shown that the aggregates are stable
in the culturemedia [8]. Controlswere performed byexposing the cells
to the same amount of native, soluble HypF-N. At the end of each
treatment, the cells were washed twice with phosphate-buffered
saline (PBS), dried and stored at−80 °C.
2.3. Sample preparation and 2D-GE
Cells were scraped in RIPA buffer (50 mM Tris–HCl pH 7.0, 1% NP-
40, 150 mM NaCl, 2 mM EGTA, 100 mM NaF) containing a cocktail of
protease inhibitors (Sigma). The cells were sonicated (10 s) and
protein extracts were clarified by centrifugation at 8000 g for 10 min.
Proteins were precipitated following a chloroform/methanol protocol
[21] and the pellet was resuspended in 8Murea, 4% CHAPS and 20mM
DTT. Three independent experiments were performed and each
sample was run in triplicate in order to assess biological and analytical
variation. IEF (first dimension) was carried out on non-linear wide-
range immobilized pH gradients (pH 3.0–10; 18 cm long IPG strips; GE
Healthcare, Uppsala, Sweden) and achieved using the Ettan™
IPGphor™ system (GE Healthcare, Uppsala, Sweden). Analytical-run
IPG strips were rehydratedwith 60 μg of total proteins in 350 μl of lysis
buffer and 0.2% carrier ampholyte for 1 h at 0 V and for 8 h at 30 V, at
20 °C. MS-preparative IPG strips were loaded with 400 μg of proteins.
The strips were focused at 20 °C according to the following electrical
conditions: 200 V for 1 h, from 300 V to 3500 V in 30 min, 3500 V for
3 h, from 3500 V to 8000 V in 30 min, and 8000 V until a total of
80,000 V/hwas reached. After focusing, analytical and preparative IPG
strips were equilibrated for 12 min in 6 M urea, 30% glycerol, 2% SDS,
2% DTT in 0.05M Tris–HCl buffer, pH 6.8, and subsequently for 5min in
the same urea/SDS/Tris buffer solution where DTT was substituted
with 2.5% iodoacetamide. The second dimensionwas carried out on 9–
16% polyacrylamide linear gradient gels (18 cm×20 cm×1.5 mm) at
10 °C and 40 mA/gel constant current until the dye front reached the
bottom of the gel. Analytical gels were stained with ammoniacal silver
nitrate as previously described [22]; MS-preparative gels were stained
with colloidal Coomassie [23].
2.4. Western blotting analysis of proteomic candidates
For 1-DE 30 μg of protein extracts was separated by 12% SDS-PAGE
and transferred onto a PVDF membrane (Millipore). To confirm the
results obtained from 2D-GE analysis, the relative amount of Hsp60
and Fak proteins were assessed by Western blot with appropriate
antibodies (Santacruz). For quantification, the blots were stained with
Coomassie brilliant blue R-250 and subjected to densitometric
analysis performed using Quantity One Software (Bio-Rad). Statistical
analysis of the data was performed by Student's t-test; p-values 0.05
were considered statistically significant. The intensity of the immu-
nostained bands were normalized with the total protein intensities
measured by Coomassie brilliant blue R-250 from the same blot.
2.5. Image analysis and statistics
The gel and Western blot images were acquired with an Epson
expression 1680 PRO scanner. For each condition, three biological
replicates were performed and only the spots present in all the
replicates were taken in consideration for subsequent analysis.
Computer-aided 2D image analysis was carried out using Image-
Master 2-DE Platinum software version 6.0 (GE Healthcare). The
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where V=integration of OD over the spot area) was used for
quantitative analysis in order to decrease experimental errors. The
normalized intensity of the spots on replicate 2D gels was averaged
and standard deviation was calculated for each condition. A two-tiled
non paired Student's t-test was performed using ORIGIN 6.0
(Microcal Software, Inc.) to determine whether the relative change
was statistically significant.
2.6. In-gel trypsin digestion and MALDI-TOF mass spectrometry
The analysis was performed on the Coomassie blue-stained spots
excised from the gels. The spots were washed first with acetonitrile
and then with 0.1 M ammonium bicarbonate. Protein samples were
reduced by incubation in 10 mM dithiothreitol (DTT) for 45 min at
56 °C. The cysteines were alkylated by incubation in 5 mM
iodoacetamide for 15 min at room temperature in the dark. The gel
particles were then washed with ammonium bicarbonate and
acetonitrile. Enzymatic digestion was carried out with trypsin
(12.5 ng/μl) in 50 mM ammonium bicarbonate buffer, pH 8.5, at
4 °C for 4 h. The buffer solutionwas then removed and a new aliquot of
the enzyme/buffer solution was added for 18 h at 37 °C. A minimum
reaction volume, enough for complete gel rehydration was used. At
the end of the incubation the peptides were extracted by washing the
gel particles with 20 mM ammonium bicarbonate and 0.1% TFA in 50%
acetonitrile at room temperature and then lyophilised. Positive
Reflectron MALDI spectra were recorded on a Voyager DE STR
instrument (Applied Biosystems, Framingham, MA). The MALDI
matrix was prepared by dissolving 10 mg of alpha cyano in 1 ml of
acetonitrile/water (90:10 v/v). Typically, 1 μl of matrix was applied to
the metallic sample plate and then 1 μl of analyte was added.
Acceleration and reflector voltages were set up as follows: target
voltage at 20 kV, first grid at 70% of target voltage, delayed extraction
at 100 ns to obtain the best signal-to-noise ratios and the best possible
isotopic resolution with multipoint external calibration using a
peptide mixture purchased from Applied Biosystems. Each spectrum
represents the sum of 1500 laser pulses from randomly chosen spots
per sample position. Raw data were analyzed using the computer
software provided by the manufacturers and are reported as
monoisotopic masses.
2.7. nanoLC mass spectrometry
A mixture of peptide solution was subjected to LC-MS analysis
using a 4000Q-Trap (Applied Biosystems) coupled to an 1100 nano
HPLC system (Agilent Technologies). The mixture was loaded on an
Agilent reverse-phase pre-column cartridge (Zorbax 300 SB-C18,
5×0.3 mm, 5 μm) at 10 μl/min (A solvent 0.1% formic acid, loading
time 5min). The peptides were separated on an Agilent reverse-phase
column (Zorbax 300 SB-C18,150mm×75 μm, 3.5 μm), at a flow rate of
0.3 μl/min with a 0% to 65% linear gradient in 60 min (A solvent 0.1%
formic acid, 2% acetonitrile in MQwater; B solvent 0.1% formic acid, 2%
MQ water in acetonitrile). Nanospray source was used at 2.5 kV with
liquid coupling, with a declustering potential of 20 V, using an
uncoated silica tip from NewObjectives (O.D. 150 μm, I.D. 20 μm, T.D.
10 μm). The data were acquired in information-dependent acquisition
(IDA) mode, in which a full scan mass spectrumwas followed by MS/
MS of the 5 most abundant ions (2 s each). In particular, spectra
acquisition of MS-MS analysis was based on a survey Enhanced MS
Scan (EMS) from 400m/z to 1400m/z at 4000 amu/s. This scanmode
was followed by an Enhanced Resolution experiment (ER) for the five
most intense ions and thenMS2 spectra (EPI) were acquired using the
best collision energy calculated on the basis of m/z values and charge
state (rolling collision energy) from 100 m/z to 1400 m/z at
4000 amu/s. The data were acquired and processed using the Analyst
software (Applied Biosystems).2.8. MASCOT analysis
The spectral data were analyzed using the Analyst software
(version 1.4.1) and the MS-MS centroid peak lists were generated
using the MASCOT.dll script (version 1.6b9). The MS-MS centroid
peaks were threshold at 0.1% of the base peak. MS-MS spectra with
less than 10 peaks were rejected. The spectra were searched against
the Swiss Prot database (2006.10.17 version) using the licensed
version of Mascot 2.1 (Matrix Science), after converting the acquired
MS-MS spectra in MASCOT generic file format. The MASCOT search
parameters were: taxonomy mus musculus; allowed number of
missed cleavages 2; enzyme trypsin; variable post-translational
modifications, methionine oxidation, pyro-glu N-term Q; peptide
tolerance 200 ppm andMS/MS tolerance 0.6 Da; peptide charge, from
+2 to +3 and top 20 protein entries. Spectra with a MASCOT score
b25 having low quality were rejected. The score used to evaluate the
quality of matches for the MS-MS data was higher than 30. However,
the spectral data were manually validated and contained sufficient
information to assign peptide sequence.
3. Results
3.1. Comparative proteomic analysis between control cells and
cells exposed to HypF-N prefibrillar aggregates
Previous experiments performed by Bucciantini et al. showed that
prefibrillar HypF-N aggregates induced early Ca2+ increase and
oxidative stress followed by mitochondria depolarization and caspase
activation in exposed NIH-3T3 cells. After 24 h, the cells died with
necrotic features possibly since the ATP levels were too low to sustain
the initially triggered apoptotic program [10]. In order to investigate
the changes (if any) in protein expression induced in the same cells
upon exposure to HypF-N prefibrillar aggregates, we performed a 2D-
GE followed by mass spectrometry. In all the experiments carried out
in this study, the cells were exposed to 2 μM prefibrillar aggregates.
This protein concentration was chosen to investigate finely regulated
biochemical processes, such as the activation of pro-apoptotic factors,
which could be hidden by a stronger cell injury [10]. The cells were
treated for 5 and 24 h and proteins extracts were prepared as
described under Materials and methods. Then the proteins were
separated by 2D-GE and the resulting silver-stained gels were
analyzed using the ImageMaster 2D Platinum 6.0 software. The
differences of protein expression between control and treated cells
were taken into consideration if the relative volume of the spots
differed reproducibly more than 1.5-fold and this difference was
statistically significant. An average of about 1300 spots was detected
in each silver-stained gel. Cell exposure to HypF-N prefibrillar
aggregates did not affect the overall proteomic profiles both after
5 h and after 24 h (Figs. 1 and 2). However, the computer analysis
highlighted 19 variations between cells treated for 5 h with 2 μM
HypF-N prefibrillar aggregates (Fig. 1B) and the control cells treated
for the same length of timewith an equivalent amount of native HypF-
N (Fig. 1A). Among these variations, only two were still present after
24 h of treatment with aggregates (Fig. 2) indicating that the
alteration of the expression is a transient event, at least for this
group of proteins, except two. On the other hand, the comparison
between cells treated for 24 h with 2 μM HypF-N prefibrillar
aggregates and control cells showed a variation of 9 spots, whose
expressionwas not affected after 5 h, indicating that some proteins are
up- or down-regulated as a consequence of the prolonged exposure to
the aggregates.
3.2. Identification of differentially expressed proteins
In order to identify the proteins of interest, 400 μg of protein
lysates was loaded on preparative gels and stained with colloidal
Fig. 1. 2D images of silver stained gels of total proteins extracted from control and HypF-N prefibrillar aggregate treated cells for 5 h. Arrows indicate variations between control
(panel A) and treated cells (panel B). Letters indicate the identified proteins. Controls were performed by exposing the cells to native, soluble HypF-N.
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in Figs. 1 and 2 were selected for mass spectral identification after
merging the images of preparative and analytical gels. The proteins
excised from the gels were reduced, alkylated and in situ digestedwith
trypsin. The resulting peptide mixtures were directly analyzed by
MALDI/MS according to the peptide mass fingerprinting procedure.
The peaks detected in theMALDI spectrawere used to search for a non
redundant sequence database using the in house MASCOT software,
taking advantage of the specificity of trypsin and the taxonomic
category of the samples. The number of measured masses that
matched within the given mass accuracy of 200 ppm was recorded
and the proteins that received the highest number of peptide matches
were examined. Some spots could not be identified unambiguously
either due to the low protein content of the spot or to the presence of
more than one protein per spot. Among the 19 spots differentially
expressed after 5 h of cell exposure to the aggregates, 13 spots wereFig. 2. 2D images of silver stained gels of total proteins extracted from control and HypF-N
(panel A) and treated cells (panel B). Numbers indicate the identified proteins. Controls wesuccessfully identified and are indicated by arrows and letters in Fig. 1.
Among the 9 spots differentially expressed in cells treated for 24 hwith
2 μM HypF-N prefibrillar aggregates, 8 spots were identified and are
indicated by arrows and numbers in Fig. 2. Some spots gave no
confident identification by the peptide mass fingerprinting procedure.
Additional data were then provided by nanoLC/MS/MS experiments.
The peptide mixtures were fractionated by nanoHPLC and sequenced
by tandemmass spectrometry leading to the unambiguous identifica-
tion of the protein candidate. The lists of proteins identified by these
approaches are reported in Table 1 (5 h treatment) and in Table 2 (24 h
treatment). The identified proteins included cytoskeleton elements
(actin, tubulin alpha 1C chain, microtubule-actin cross-linking factor
1), enzymes involved in energy metabolism and transcriptional
regulation (Gapdh, enolase), proteins involved in stress response
(Hsp60 and 78 kDa glucose-regulated protein) and the focal adhesion
kinase, Fak1. Among these proteins only Fak1 and Hsp60 showed anprefibrillar aggregate treated cells for 24 h. Arrows indicate variations between control
re performed by exposing the cells to native, soluble HypF-N.
Table 1
Relative change in protein expression in cells treated for 5 h with HypF-N prefibrillar aggregates versus control cells.
Spot Protein name Accession
number
MASCOT
score
No. of matched
peptides
Sequence
coverage (%)
Fold change p-value Functional categorization
Up-regulated by HypF-N
A Hsp60 P63038 162 5 12% +1.58 0.0005 Protein folding and stress response
B Actin P60710 79 5 22% Only in treated cells. N.D. Cytoskeletal organization
C Actin P60710 241 7 18% +9.8 0.007 Cytoskeletal organization
D Glyceraldehyde-3-phosphate
dehydrogenase
P16858 120 7 33% +9.7 0.0081 Energy related (glycolysis)
E 78 kDa glucose-regulated
protein
P20029 78 2 5% +4.8 0.1 Protein folding and stress response
(response to unfolded proteins)
F Nucleophosmin Q61937 165 5 15% Only in treated cells. N.D. Associated with nucleolar
ribonucleoprotein structures and
bind single-stranded nucleic acids
Down-regulated by HypF-N
G Focal Adhesion kinase-1 P34152 77 17 22% −1.6 0.01 Non-receptor protein-tyrosine kinase
involved in cell motility. Proliferation
and apoptosis.
H Enolasi-1 P17182 118 12 32% −2.4 0.09 Energy related (glycolysis)
I Tubulin alpha-1C chain P68373 80 9 31% −8.3 0.015 Major constituent of microtubules
J Annexin-A3 O35639 111 13 43% −2 0.019 Inhibitor of phospholipase A2
K Hsp60 P63038 85 2 5% −1.6 0.032 Protein folding and stress response
L Transgelin-2 Q9WVA4 171 7 41% Only in control cells N.D. Belongs to the calponin family
M Heparan sulfate glucosamine
3-O-sulfotransferase 2
Q673U1 47 2 4% Only in control cells N.D. Catalyzes the O-sulfation of glucosamine
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after 5 and after 24 h of cell exposure to the aggregates.
3.3. Validation of proteomics results
In order to validate the proteomic results, the amounts of Fak1 and
Hsp60 were evaluated by Western blot analysis with specific
antibodies as shown in Fig. 3, panels A and B, respectively. Thirty μg
of proteins was loaded on 12% SDS-PAGE and transferred onto a PVDF
membrane. For quantification, the intensities of the immunostained
bands were normalized to the total protein intensities in the same
blot, as measured by Coomassie brilliant blue. In Fig. 3, panel C the
histograms representing the variation of the expression of Fak1 and
Hsp60 are also reported. Such analysis confirmed the decrease of
Fak1 expression and the increase of Hsp60 expression both after 5.0
and 24 h.
3.4. Protein expression changes in cells exposed for 5 h to HypF-N
prefibrillar aggregates
In cells exposed to HypF-N prefibrillar aggregates for 5 h, 6 spots (A
to F in Table 1) appeared up-regulated, whereas 7 spots (G to M inTable 2
Relative change in protein expression in cells treated for 24 h with HypF-N prefibrillar aggr
Spot Protein name Accession
number
MASCOT
score
No. of matched
peptides
Up-regulated by HypF-N
1 Ovostatin homolog Q3UU35 48 4
2 Hsp60 P63038 162 5
Down-regulated by HypF-N
3 Microtubule-actin
cross-linking factor 1
Q9QXZ0 82 14
4 Microtubule-actin
cross-linking factor
Q9QXZ0 88 10
5 Pol protein Q7M6W3 73 10
6 Pdia2 protein Q14AV9 43 2
7 Poly(rC)-binding
protein 2
Q61990 71 2
8 Fak1 focal adhesion
kinase
P34152 77 17Table 1) appeared down-regulated. Among the up-regulated proteins,
we found the heat shock protein Hsp60 (spot A). Hsp60 belongs to a
family of highly homologous chaperone proteins that are induced in
response to environmental, physical and chemical stresses, including
accumulations of misfolded proteins and reactive oxygen species [24,
25]. The increase of Hsp60 expression limits the consequences of
damage facilitating cell recovery. Hsp60 was also identified in the spot
K, which was down-regulated upon cell treatment with the
aggregates. However, the position in the gel and the peptide coverage,
indicates that this spot is probably a fragment arising from a
proteolytic cleavage of Hsp60.
A further indication of a stress condition induced in cells exposed
to the HypF-N aggregates is the marked increase in the expression of
the key glycolytic enzyme Gapdh (spot D). This protein plays a central
role in glycolysis, catalyzing the reversible conversion of glyceralde-
hyde-3-phosphate to 1,3-bisphosphoglycerate. More recent studies
have highlighted unexpected non-glycolytic functions of Gapdh in
physiological and pathological processes, including transcriptional
regulation of cell-cycle [19]. In addition two spots corresponding to
actin were up-regulated. Among the proteins whose expression
appeared decreased upon exposure to HypF-N prefibrillar aggregates,
the focal adhesion kinase (Fak1; spot G) is particularly interesting.egates versus control cells.
Sequence
coverage (%)
Fold
change
p-value Functional categorization
15% +1.4 0.028 Proteases inhibitor
12% +1.58 0.0005 Protein folding and stress response
10% −1.66 0.035 F-actin-binding protein which may
play a role in cross-linking actin to
other cytoskeletal proteins
8% −2.24 0.023
17% −1.67 0.1 Unknown
5% −3.21 0.004 Protein disulfide isomerase
6% −3.78 0.014 Single-stranded nucleic acid
binding protein
22% −1.53 0.015 Non-receptor protein-tyrosine
kinase involved in cell motility,
proliferation and apoptosis
Fig. 3. Validation of proteomic results by western blot analysis. Western blot were probed with antibodies against Fak1 and Hsp60 proteins identified by proteomic screening. The
intensity of immunostained bands was normalized with the total protein intensities measured from the same blot stained with Coomassie brilliant blue (in panel A and panel B a
representative band of the lane is reported). (A) Aggregate-induced reduced expression of Fak1 after 5 and 24 h of treatment: lane 1, cells exposed to native HypF-N; lane 2, cells
exposed to HypF-N prefibrillar aggregates. (B) Aggregate-induced increased expression of Hsp60 after 5 and 24 h of treatment: lane 1, cells exposed to native HypF-N; lane 2, cells
exposed to HypF-N prefibrillar aggregates. (C) Histograms representing Fak1 and Hsp60 protein expression variation. The two-tailed non paired Student’s t-test was performed using
ORIGIN 6.0. (pb0.05).
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role in the regulation of proliferation and migration of normal and
tumour cells [26, 27]. Interestingly, Fak1 and Hsp60 are the only two
proteins, among those differentially expressed after 5 h of cell
exposure, that do not recover a normal expression level after 24 h.
3.5. Protein expression changes in cells exposed for 24 h to HypF-N
prefibrillar aggregates
It was previously shown that NIH-3T3 cells treated for 24 h with
10 μM HypF-N prefibrillar aggregates die with necrotic features,
including cytoplasmic vacuolization and nuclear swelling after an
initial apoptotic activation [10]. The amount of HypF-N aggregates
(2 μM, soluble protein concentration) used in this work is not so high
to induce cell death, thus allowing the cells to overcome damage. After
24 h of cell exposure to HypF-N aggregates, few other proteins, besides
Fak1 and Hsp60, displayed altered expression. In particular, we
identified 6 new spots (1 up-regulated and 5 down-regulated).
Among the proteins down-regulated, the microtubule-actin cross-
linking factor 1 (MACF1, spot 3) belongs to the Plakin family, that
includes proteins involved in the linkage of cytoskeletal elements and
the junctional complex. MACF1 was found to regulate microtubule
remodelling in response to the activation of signal transductionTable 3
Protein expression changes observed in this study in comparison to previous protein repor
Protein Amyloid aggregates
GAPDH HypF-N
Amyloid β-peptide
β-amyloid (1–42)
Tubulin α-chain HypF-N
β-amyloid (1–42)
β-amyloid (1–42)
78 kDa glucose-regulated protein HypF-N
β-amyloid (1–42)
Enolase HypF-N
Hsp60
Actin HypF-N
β-amyloid (1–42)pathways, although its function has not yet been fully explored
[28, 29].
4. Discussion
To our knowledge, this study is the first proteomic investigation
focused on highlighting the alterations of the protein expression
profiles in a cultured cell model exposed to toxic amyloid aggregates
of a protein not involved in any amyloid disease. Our analysis was
performed using a non lethal dose of HypF-N prefibrillar aggregates,
allowing the detection of fine variations more directly implicated in a
response to the cell injury given by the aggregates, instead of the
complex pattern of changes arising during the process of cell death.
Our approach led us to identify a subset of cell proteins whose levels
were significantly altered upon cell exposure to the aggregates for 5 h or
24 h. Some of the proteins detected in our investigation, including
Hsp60, actin, enolase-1 and Gapdh had previously been identified in
other proteomic studies carried out on cells exposed to Aβ42 or α-
synuclein. In Table 3 a comparison between the protein identified in our
study and the proteins identified in other studies is shown, indicating
that there is a general response of cells to toxic aggregates that is not
sequence specific [12,13,30,31,32]. Actually, changes in the expression
levels of Gapdh, actin, tubulin and heat shock proteins have frequentlyted in other studies.
Cell type or animal model
NIH3T3 fibroblast cells This study
Mitochondria from primary neuron [30]
Tg2576 transgenic mice [31]
3xTgAD Alzheimer's mice (hippocampal protein) [12]
P301L tau overexpressing SH-SY5Y [32]
NIH3T3 fibroblast cells This study
SN56.B5.G4 cholinergic cells [13]
3xTgAD Alzheimer's mice (hippocampal protein) [12]
Amygdalae from P301L tau transgenic mice [32]
NIH3T3 fibroblast cells This study
3xTgAD Alzheimer's mice (hippocampal protein) [12]
P301L tau overexpressing SH-SY5Y [32]
NIH3T3 fibroblast cells This study
Tg2576 transgenic mice [31]
3xTgAD Alzheimer's mice (hippocampal protein) [12]
3xTgAD Alzheimer's mice [12]
NIH3T3 fibroblast cells This study
Amygdalae from P301L tau transgenic mice [32]
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they are related to a generic response to stress conditions [33] such as
that associated with the growth of amyloid aggregates. In our
experiments, cell exposure to toxic amyloid aggregates induced an
increase of the expression levels of several proteins such as Hsp60. In
addition to its chaperone activity, Hsp60 has been suggested to perform
complex functions, producing both anti- and pro-apoptotic effects. In
fact, cytosolic Hsp60, can promote either cell survival or caspase-
mediated cell death by preventing the translocation of the pro-apoptotic
protein Bax into the mitochondria or by favouring the maturation of
procaspase-3, respectively [34–38]. In a recent study, Hsp60, Hsp70, and
Hsp90 were shown to provide differential protection against intracel-
lular stress caused by β-amyloid by maintaining the efficiency of the
mitochondrial oxidative phosphorylation and the tricarboxylic acid
cycle enzymes. In particular, Hsp60was shown to prevent the inhibition
of complex IV activity by β-amyloid, thus preventing apoptosis [39].
We also found significantly increased levels of Gapdh and actin. As far
as Gapdh is concerned, several recent studies have shown that, in addition
to glycolysis, it is involved in several glycolysis-unrelated activities; these
include a role in vesicle fusion and transport [40], microtubule bundling
[41], nuclear RNA transport [42], and transcription [43]. Furthermore,
increased expression and nuclear translocation of Gapdh have recently
been reported to participate to the apoptotic pathway in different cell
types [44–47]. Finally, Gapdh has also been reported to bind to a variety of
proteins involved in neuronal diseases, including the amyloid precursor
protein and huntingtin [18]. The increased levels of actin expression in
cells exposed to prefibrillar HypF-N aggregates are similar to the effects
previously reported byMuller et al.; these authors found up-regulation of
the actin gene expression in cells harbouring the cytoplasmic domain of
the amyloid precursor protein [20].
Finally, we found a significant decrease of Fak1 in cells exposed
both 5 h and 24 h to the HypF-N aggregates. The repression of Fak1
synthesis in exposed cells, confirmed by Western blot analysis, is one
of the major results of this proteomic analysis. In vivo animal studies
have shown that Fak1 expression is increased in a number of human
cancers, thus contributing to tumour development and malignancy
[48]. Moreover, Fak1 has recently been shown to be a critical protein in
survival signalling, since it blocks apoptosis induced by several stimuli
[49]. Fak1 expression decrease following proteolytic cleavage in
various cell types has been associated with various cell dysfunctions
including c-Myc-induced apoptosis of chicken embryo fibroblasts
(CEF) [49], growth factor deprivation-induced apoptosis of human
umbilical vein endothelial cells [50], and detachment-induced cell
death (anoikis) of intestinal epithelial cells [51]. In a recent study,
different epithelial cell lines treated with thimerosal displayed
increased levels of hydrogen peroxide resulting in caspase activation,
Fak1 cleavage and apoptosis [52]. All these observations suggest that
the decreased Fak1 expression in NIH-3T3 cells treated with HypF-N
aggregates could be related to the apoptotic process: in particular its
decreased intracellular levels could be the consequence of a
proteolytic cleavage making the cells more vulnerable to death.
The reported changes in protein expression profiles in exposed
cells suggest some alterations in specific signalling pathways involved
in the control of gene transcription and translation and/or in protein
degradation pathways. These alterations could be triggered, at least in
part, by modifications of signalling pathways following the reported
interaction of amyloid aggregates with the cell membrane [10, 11, 53].
Overall, our results can provide useful information on the crucial
events underlying cytotoxicity induced by amyloid aggregates of
different peptides or proteins both related and unrelated to disease.
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